Proton Particle Therapy for Arrhythmia

Phase-Based Progress Estimates
Mayo Clinic in Rochester, Rochester, MNArrhythmiaProton Particle Therapy - Radiation
18 - 80
All Sexes
What conditions do you have?

Study Summary

This trial is testing whether proton therapy can help people with ventricular tachycardia who have already had an implantable cardioverter defibrillator and catheter ablation.

Eligible Conditions
  • Arrhythmia

Treatment Effectiveness

Study Objectives

4 Primary · 0 Secondary · Reporting Duration: 2 years

2 years
Cardiac Arrest
Implantable Cardioverter Defibrillator (ICD) Shocks
Recurrent Ventricular Tachycardia (VT)

Trial Safety

Trial Design

1 Treatment Group

Proton Particle Therapy for Cardiac Arrhythmia
1 of 1

Experimental Treatment

10 Total Participants · 1 Treatment Group

Primary Treatment: Proton Particle Therapy · No Placebo Group · N/A

Proton Particle Therapy for Cardiac Arrhythmia
Experimental Group · 1 Intervention: Proton Particle Therapy · Intervention Types: Radiation

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 2 years

Who is running the clinical trial?

Douglas L. Packer, MDLead Sponsor
Douglas L Packer, MDPrincipal InvestigatorMayo Clinic
1 Previous Clinical Trials
172 Total Patients Enrolled
1 Trials studying Arrhythmia
172 Patients Enrolled for Arrhythmia

Eligibility Criteria

Age 18 - 80 · All Participants · 7 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have had a heart procedure called "ablation" done from outside the heart without prior surgery, or the study doctor does not think it is appropriate for you.
You have already undergone a catheter-based ablation for VT/VF, but it didn't work, and you can't have another one. You have also tried medication options for at least 9 months, but they didn't help.

Frequently Asked Questions

Are there any open slots within this trial for enrollees?

"According to the information displayed on, this trial is still in need of participants. This medical study was first published on March 19th 2021 and its most recent update took place on April 28th 2022." - Anonymous Online Contributor

Unverified Answer

Does this clinical research permit geriatric participation?

"This clinical trial is only open to individuals between 18-80 years of age. For younger patients, 8 trials are available; older participants can join 70 different studies." - Anonymous Online Contributor

Unverified Answer

How many participants have been approved to partake in this medical experiment?

"Absolutely, patient recruitment for the trial is still underway. The study was initially posted on March 19th 2021 and underwent its most recent update on April 28th 2022. As of now, 10 participants need to be enrolled from a single medical centre." - Anonymous Online Contributor

Unverified Answer

Who qualifies to take part in this clinical trial?

"Admittance requirements for this trial include having a diagnosis of arrhythmia and being between 18-80 years old. The study is expected to enroll around 10 participants." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.